Neoadjuvant chemoradiotherapy could improve survival outcomes for esophageal carcinoma: A meta-analysis

Digestive Diseases and Sciences

Volumn 57, Issue 12, 2012, Pages 3226-3233

  Wang, Dong Bin ^a,b   Zhang, Xun ^b   Han, Hong Li ^b   Xu, Yi Jun ^b   Sun, Da Qiang ^b   Shi, Zhen Liang ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN CHEST HOSPITAL   (China)

Author keywords

Esophageal carcinoma; Meta analysis; Neoadjuvant chemoradiotherapy; Randomized controlled trial; Subgroup analysis

Indexed keywords

ADJUVANT CHEMORADIOTHERAPY; ARTICLE; CANCER MORTALITY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; ESOPHAGUS CARCINOMA; HUMAN; INTERMETHOD COMPARISON; META ANALYSIS; MORBIDITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; HUMANS; RADIOTHERAPY, ADJUVANT;

EID: 84871639192     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-012-2263-8     Document Type: Article

References (32)

1. Daly JM, Karnell LH, Menck HR. National cancer data base report on esophageal carcinoma. Cancer. 1996;78:1820-1828.
2. Hulscher JB, van Sandick JW, de Boer AG, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. New Engl J Med. 2002;347:1662-1669.
3. Fiorica F, Di Bona D, Schepis F, et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004;53:925-930.
4. Urschel JD, Vasan H. A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg. 2003;185:538-543.
5. Kaklamanos IG, Walker GR, Ferry K, Franceschi D, Livingstone AS. Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials. Ann Surg Oncol. 2003;10:754-761.
6. Malthaner RA, Wong RK, Rumble RB. Members of the gastrointestinal cancer disease site group of cancer care Ontario's program in evidence-based care. Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med. 2004;2:35-51.
7. Greer SE, Goodney PP, Sutton JE, Birkmeyer JD. Neoadjuvant chemoradiotherapy for esophageal carcinoma: a meta-analysis. Surgery. 2005;137:172-177.
8. Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007;8:226-234.
9. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD. Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J Gastroenterol. 2009;15:4962-4968.
10. Moher D, Liberati A, Tetzlaff J. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269.
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12.
12. Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992;16:1104-1109.
13. Apinop C, Puttisak P, Preecha N. A prospective study of combined therapy in esophageal cancer. Hepato-Gastroenterol. 1994;41:391-393.
14. Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer. 1994;73:1779-1784.
15. Walsh TN, Noonan N, Hollywood D, Kelly A, Keeling N, Hennessy TP. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996;335:462-467.
16. Bosset JF, Gignoux M, Triboulet JP, et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997;337:161-167.
17. Urba SG, Orringer MB, Turrisi A, Iannettoni M, Forastiere A, Strawderman M. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001;19:305-313.
18. An FS, Huang JQ, Xie YT, Chen SH, Rong TH. A prospective study of combined chemoradiotherapy followed by surgery in the treatment of esophageal carcinoma. Zhonghua Zhong Liu Za Zhi. 2003;25:376-379.
19. Lee JL, Park SI, Kim SB, et al. A single institutional phase III trial of preoperative chemotherapy with hyperfractionation radiotherapy plus surgery versus surgery alone for resectable esophageal squamous cell carcinoma. Ann Oncol. 2004;15:947-954.
20. Burmeister BH, Smithers BM, Gebski V, et al. A randomised controlled phase III trial. Lancet Oncol. 2005;6:659-668.
21. Natsugoe S, Okumura H, Matsumoto M, et al. Randomized controlled study on preoperative chemoradiotherapy followed by surgery versus surgery alone for esophageal squamous cell cancer in a single institution. Dis Esophagus. 2006;19:468-472.
22. Tepper J, Krasna MJ, Niedzwiecki D, et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008;26:1086-1092.
23. Cao XF, He XT, Ji L, Xiao J, Lv J. Effects of neoadjuvant radiochemotherapy on pathological staging and prognosis for locally advanced esophageal squamous cell carcinoma. Dis Esophagus. 2009;22:477-481.
24. Bedenne L, Faivre J, Boutron MC, et al. Cancer of the esophagus in the department of Cote-d'Or. Bull Cancer. 1986;73:526-534.
25. Cherie-Challine L, Pottier D, Gignoux M. Descriptive epidemiology of cancer of the esophagus in the Department of Calvados: 520 cases (1978-1982). Gastroenterol Clin Biol. 1988;12:126-132.
26. Calament G, Cauvin JM, Robaskiewicz M, et al. Treatment of and survival after epidermoid cancer of the esophagus in the department of Finistere between 1984 and 1988 (716 cases). Gastroenterol Clin Biol. 1993;17:9-16.
27. Arnott SJ, Duncan W, Kerr GR, et al. Low dose preoperative radiotherapy for carcinoma of the oesophagus: results of a randomized clinical trial. Radiother Oncol. 1992;24:108-113.
28. Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery. 1993;113:138-147.
29. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft Fuer Onkologie der Deutschen Gesellschaft Fuer Chirurgie Study Group. Arch Surg. 1992;127:1446-1450.
30. van Meerten E, Muller K, Tilanus HW, et al. Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study. Br J Cancer. 2006;94:1389-1394.
31. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011;12:681-692.
32. Jin HL, Zhu H, Ling TS, et al. Neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: a meta-analysis. World J Gastroentero. 2009;15:5983-5991.